#Japan #Tokyo #Pet Products #wellness care #Wellpharma

Wellpharma's Strategic Relocation to Enhance Wellness Care

Wellpharma Co., Ltd., renowned for providing evidence-based wellness care, has announced the relocation of its headquarters and factory to a new address effective December 1, 2025. This strategic move aims to bolster the company's production capabilities and support its expansion strategy, thereby enhancing the overall wellness offerings for both humans and animals.

Reasons for the Relocation

As a company on a mission to comprehensively support the wellness of both people and their pets, Wellpharma has continually invested in strengthening its product development and service systems. In recent years, the company has witnessed a steady increase in sales and customer base, necessitating a more robust research and development initiative as well as an improved production management framework. Consequently, the decision to move to a new headquarters and factory was made to address these growing demands.

The relocation is set to enhance product supply stability and improve quality control accuracy, ensuring that they continue to provide meaningful value tailored to both human and animal wellness needs.

New Address

• - New Headquarters and Factory Address: 5-26-12 Minami-Oi, Shinagawa-ku, Tokyo 140-0013, Japan.

Key Features of the New Facility

1. A Focus on Employee and Pet Well-being

The design of the new office prioritizes the well-being of both employees and their pets. A newly constructed break room is equipped with a coffee machine and water dispenser to enhance comfort. Moreover, the entire office features wall-to-wall carpeting, creating a safe environment for pets – an aspect that aligns perfectly with the previously established pet-friendly office policy.


Here, employees are also encouraged to utilize the nearby parks for short walks during their